Researchers unveil unique autoantibody profiles in rheumatoid arthritis patients

FHS
May 2, 2024
11:42 am

Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease.

Three months after delisting, NGM Bio is back with $122M for slimmed-down pipeline

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 18, 2024

Flagship launches AI-powered biologics biotech with $50M backing

Flagship Pioneering has unveiled a new biotech that’s on a mission to build a new class of biologics with the help of AI. Abiologics, which

July 24, 2024

When can observational studies support a drug’s effectiveness? FDA explains in new draft guidance

The FDA on Wednesday released highly-anticipated draft guidance on when drug sponsors can use observational studies to help demonstrate a drug’s effectiveness, for the first

March 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.